The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a six week campaign to encourage members of the general public to report suspected adverse drug reactions (ADRs). The BBC has reported this campaign.
The scheme will see the distribution of materials to pharmacies including updated Yellow Card reporting forms, information leaflets and a poster for display in the pharmacy. It is hoped that this scheme will promote greater use of the new, easier to use forms. Reporting of any suspected reaction is encouraged, including reactions already listed in information leaflets or mentioned by healthcare professionals.
Patients may approach healthcare professionals asking for more information about how they can submit a report and seeking reassurance that the report should be submitted at all.
Action: Clinicians should be aware of this campaign and support reporting of any suspected ADR.
|« Nursing integrity reduced by industry promotion||MTRAC reviews dementia drugs »|